Kjeldsen JW, Lorentzen CL, Martinenaite E, Ellebaek E, et al. Author Correction: A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma. Nat Med 2022 Mar 8. pii: 10.1038/s41591-022-01771.
PMID: 35260843